Adult patient preferences for long-acting ADHD treatments: A discrete choice experiment

Authors

M Janelle Cambron-Mellott, Kantar Health
Jaromir Mikl, Purdue Pharma L.P./Adlon Therapeutics, L.P.
Joana E Matos, Kantar Health
Jennifer G Erensen, Purdue Pharma L.P./Adlon Therapeutics, L.P.
Kathleen Beusterien, Kantar Health
Marc J Cataldo, Purdue Pharma L.P./Adlon Therapeutics, L.P.
Bernadette Hallissey, Kantar Health
Gregory W Mattingly, Washington University School of Medicine in St. Louis

Journal

Patient Prefer Adherence

Publication Date

2021

Volume

15

First Page

1061

Last Page

1073

Document Type

Open Access Publication

DOI

10.2147/PPA.S311836

Rights and Permissions

Cambron-Mellott MJ, Mikl J, Matos JE, et al. Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment. Patient Prefer Adherence. 2021;15:1061-1073. Published 2021 May 21. doi:10.2147/PPA.S311836.

Recommended Citation

Cambron-Mellott, M Janelle; Mikl, Jaromir; Matos, Joana E; Erensen, Jennifer G; Beusterien, Kathleen; Cataldo, Marc J; Hallissey, Bernadette; and Mattingly, Gregory W, "Adult patient preferences for long-acting ADHD treatments: A discrete choice experiment." Patient Prefer Adherence. 15, 1061 - 1073. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10670